Funder
National Research Foundation of Korea
Subject
Pharmacology,General Medicine
Reference17 articles.
1. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis;Pethe;Nat. Med,2013
2. Telacebec (Q203), a new antituberculosis agent;de Jager;N. Engl. J. Med.,2020
3. Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption;Matsoso;J. Bacteriol.,2005
4. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds;Moraski;PLoS One,2020
5. Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the treatment of tuberculosis: a randomized, placebo-controlled, multiple ascending dose phase 1B Trial;Kim;Antimicrob. Agents Chemother.,2023